› Forums › General Melanoma Community › New anti-PD1 trials and others! Check this site!
- This topic has 3 replies, 1 voice, and was last updated 11 years, 11 months ago by
Mat.
- Post
-
- February 27, 2014 at 1:08 am
Clinical Trial # = NCT01621490
Phase 1 Biomarker study in advanced melanoma
BMS sponsored trial of Nivolumab at 3mg/kg every 2 weeks for 2 years, depending on response, while measuring biomarkers.
Sites actively recruiting include: Los Angeles, Boston, New York, Portland, Nashville, Houston.
Requirements: No brain mets, measurable disease, etc.Clinical Trial # = NCT01703507
Phase 1 Ipi and Whole brain or SRS in treating melanoma with brain mets
Sites actively recruiting – Thomas Jefferson University, Philadelphia
Will soon be opening at Ohio State UniversityClinical Trial # = NCT01672450
Phase 1 with Intratumoral injection of IL2 and ipi in patients with unresectable Stage III or IV
Requires accessible tumors.
Site = Salt Lake City UtahClinical Trial # = NCT01497808
Stratified Phase 1/2 dose escalation trial of SRS (stereotactic body radiotherapy) followed by ipi in metastatic melanoma.
Sites actively recruiting = Philadelphia
Only 4 of 40 slots filled per site.Obviously each trial and site has their own particulars. Check out the link below for more trials and information!!!! Please….if you are interested in any of them…CALL the location indicated!
Mdlinx.com for more clinical melanoma trials
Celeste
- Replies
- You must be logged in to reply to this topic.